0001628280-25-024000.txt : 20250508 0001628280-25-024000.hdr.sgml : 20250508 20250508193441 ACCESSION NUMBER: 0001628280-25-024000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250505 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yanai Shlomo CENTRAL INDEX KEY: 0001562645 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 25927935 MAIL ADDRESS: STREET 1: 677 WASHINGTON BLVD STREET 2: SUITE 1100 CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 wk-form4_1746747275.xml FORM 4 X0508 4 2025-05-05 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001562645 Yanai Shlomo C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 1 0 0 0 0 Class A Common Stock 2025-05-05 4 M 0 40258 A 285985 D Restricted Stock Units 2025-05-05 4 M 0 40258 0 D Class A Common Stock 40258 0 D Restricted Stock Units 2025-05-06 4 A 0 34819 0 A Class A Common Stock 34819 34819 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025. Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. /s/ Denis Butkovic, Attorney-in-Fact 2025-05-08